Fennec Pharmaceuticals Inc.FENCNASDAQ
LOADING
|||
Operating Income Scaling
Trending higher, above historical average.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$2.57M
↑ 125% above average
Average (9y)
$-10.23M
Historical baseline
Range
High:$2.57M
Low:$-21.69M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $2.57M | +120.1% |
| 2023 | $-12.77M | +41.1% |
| 2022 | $-21.69M | -27.1% |
| 2021 | $-17.07M | +4.5% |
| 2020 | $-17.89M | -34.4% |
| 2019 | $-13.31M | -27.9% |
| 2018 | $-10.41M | -49.7% |
| 2017 | $-6.95M | -142.1% |
| 2016 | $-2.87M | -51.9% |
| 2015 | $-1.89M | - |